A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 18, Issue 10, Pages 1570-1574
Publisher
Springer Nature
Online
2012-10-01
DOI
10.1038/nm.2942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
- (2012) J. S. Powell et al. BLOOD
- A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
- (2012) Vinay Bhaskar et al. DIABETES
- Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice
- (2012) Q. SHI et al. HAEMOPHILIA
- Modern haemophilia care
- (2012) Erik Berntorp et al. LANCET
- Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight
- (2011) S. Bjorkman et al. BLOOD
- The principal results of the International Immune Tolerance Study: a randomized dose comparison
- (2011) C. R. M. Hay et al. BLOOD
- Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project
- (2011) K. FISCHER et al. HAEMOPHILIA
- Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres
- (2011) M. V. RAGNI et al. HAEMOPHILIA
- Clinical severity of haemophilia A: does the classification of the 1950s still stand?
- (2011) I. E. M. Den UIJL et al. HAEMOPHILIA
- Gene therapy for haemophilia: a long and winding road
- (2011) K. A. HIGH JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
- (2011) Rong Deng et al. mAbs
- Engineering the variable region of therapeutic IgG antibodies
- (2011) Tomoyuki Igawa et al. mAbs
- Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors
- (2011) Cindy Leissinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options
- (2010) Shrimati Shetty et al. AUTOIMMUNITY REVIEWS
- Improvements in factor concentrates
- (2010) David Lillicrap CURRENT OPINION IN HEMATOLOGY
- Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling
- (2010) Janet Jackman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Reduced elimination of IgG antibodies by engineering the variable region
- (2010) T. Igawa et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Intrachain disulfide bond in the core hinge region of human IgG4
- (2010) James W. Bloom et al. PROTEIN SCIENCE
- A study of variations in the reported haemophilia A prevalence around the world
- (2009) J. S. STONEBRAKER et al. HAEMOPHILIA
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New assays for monitoring haemophilia treatment
- (2008) M. SHIMA et al. HAEMOPHILIA
- Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice
- (2008) A. V. Mayorov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now